No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SYRE Spyre Therapeutics
- 22.460
- -1.560-6.49%
Close Jan 10 16:00 ET
- 22.460
- 0.0000.00%
Post 16:20 ET
1.32BMarket Cap-14.97P/E (TTM)
23.760High21.600Low687.24KVolume23.290Open24.020Pre Close15.22MTurnover1.50%Turnover RatioLossP/E (Static)58.67MShares47.97052wk High7.68P/B1.03BFloat Cap20.07052wk Low--Dividend TTM45.73MShs Float318.750Historical High--Div YieldTTM8.99%Amplitude2.650Historical Low22.147Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Spyre Therapeutics Added to the Nasdaq Biotechnology Index
LifeSci Capital Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $50
BTIG Maintains Spyre Therapeutics(SYRE.US) With Buy Rating, Maintains Target Price $70
Promising Potential of Spyre Therapeutics' SPY002 Drives Buy Rating Amid Robust Anti-TL1A Market
Spyre Therapeutics Analyst Ratings
JonesTrading Initiates Spyre Therapeutics(SYRE.US) With Hold Rating
Heat List
US
Overall
Symbol
Price
% Chg
No Data